189 related articles for article (PubMed ID: 24755007)
1. Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial.
Vranckx P; Leonardi S; Tebaldi M; Biscaglia S; Parrinello G; Rao SV; Mehran R; Valgimigli M
Eur Heart J; 2014 Oct; 35(37):2524-9. PubMed ID: 24755007
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
Kikkert WJ; van Geloven N; van der Laan MH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
J Am Coll Cardiol; 2014 May; 63(18):1866-75. PubMed ID: 24657697
[TBL] [Abstract][Full Text] [Related]
3. Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
Vranckx P; White HD; Huang Z; Mahaffey KW; Armstrong PW; Van de Werf F; Moliterno DJ; Wallentin L; Held C; Aylward PE; Cornel JH; Bode C; Huber K; Nicolau JC; Ruzyllo W; Harrington RA; Tricoci P
J Am Coll Cardiol; 2016 May; 67(18):2135-2144. PubMed ID: 27151345
[TBL] [Abstract][Full Text] [Related]
4. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention.
Matic DM; Milasinovic DG; Asanin MR; Mrdovic IB; Marinkovic JM; Kocev NI; Marjanovic MM; Antonijevic NM; Vukcevic VD; Savic LZ; Zivkovic MN; Mehmedbegovic ZH; Dedovic VM; Stankovic GR
Heart; 2014 Jan; 100(2):146-52. PubMed ID: 24179161
[TBL] [Abstract][Full Text] [Related]
6. Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.
Gargiulo G; Ariotti S; Santucci A; Piccolo R; Baldo A; Franzone A; Magnani G; Marino M; Esposito G; Windecker S; Valgimigli M
JACC Cardiovasc Interv; 2016 Sep; 9(17):1780-9. PubMed ID: 27544007
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of new bleeding criteria: a prospective study of evaluation for the Bleeding Academic Research Consortium definition of bleeding in patients undergoing percutaneous coronary intervention.
Choi JH; Seo JM; Lee DH; Park K; Kim YD
J Cardiol; 2015 Apr; 65(4):324-9. PubMed ID: 25066338
[TBL] [Abstract][Full Text] [Related]
8. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.
Ndrepepa G; Schuster T; Hadamitzky M; Byrne RA; Mehilli J; Neumann FJ; Richardt G; Schulz S; Laugwitz KL; Massberg S; Schömig A; Kastrati A
Circulation; 2012 Mar; 125(11):1424-31. PubMed ID: 22344040
[TBL] [Abstract][Full Text] [Related]
10. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
Costa F; Vranckx P; Leonardi S; Moscarella E; Ando G; Calabro P; Oreto G; Zijlstra F; Valgimigli M
Eur Heart J; 2015 May; 36(20):1242-51. PubMed ID: 25718355
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
[TBL] [Abstract][Full Text] [Related]
12. Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention.
Hara H; Takahashi K; Kogame N; Tomaniak M; Kerkmeijer LSM; Ono M; Kawashima H; Wang R; Gao C; Wykrzykowska JJ; de Winter RJ; Neumann FJ; Plante S; Lemos Neto PA; Garg S; Jüni P; Vranckx P; Windecker S; Valgimigli M; Hamm C; Steg PG; Onuma Y; Serruys PW
Circ Cardiovasc Interv; 2020 Sep; 13(9):e009177. PubMed ID: 32838554
[TBL] [Abstract][Full Text] [Related]
13. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ;
Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378
[TBL] [Abstract][Full Text] [Related]
14. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).
Hochholzer W; Wiviott SD; Antman EM; Contant CF; Guo J; Giugliano RP; Dalby AJ; Montalescot G; Braunwald E
Circulation; 2011 Jun; 123(23):2681-9. PubMed ID: 21606391
[TBL] [Abstract][Full Text] [Related]
15. Performance of PRECISE-DAPT Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy.
Choi SY; Kim MH; Cho YR; Sung Park J; Min Lee K; Park TH; Yun SC
Circ Cardiovasc Interv; 2018 Dec; 11(12):e006837. PubMed ID: 30545256
[TBL] [Abstract][Full Text] [Related]
16. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial.
Ducrocq G; Schulte PJ; Becker RC; Cannon CP; Harrington RA; Held C; Himmelmann A; Lassila R; Storey RF; Sorbets E; Wallentin L; Steg PG
EuroIntervention; 2015 Nov; 11(7):737-45. PubMed ID: 25254357
[TBL] [Abstract][Full Text] [Related]
17. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
[TBL] [Abstract][Full Text] [Related]
19. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction.
Zhang JH; Tang XF; Zhang Y; Wang J; Yao Y; Ma YL; Xu B; Gao RL; Gao Z; Chen J; Song L; Wu Y; Meng XM; Yuan JQ
Thromb Res; 2014 Nov; 134(5):970-5. PubMed ID: 25217066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
